Business UpdateJun 9, 2026, 08:31 AM
Microbot Medical Secures First Midwest Account for LIBERTY System
AI Summary
Microbot Medical Inc. announced it has secured its first Midwest-based account, a major healthcare system in Michigan, for its LIBERTY Endovascular Robotic System. This expansion into Michigan and the greater Midwest follows a recent customer acquisition in North Carolina, demonstrating the company's continued execution of its full market release strategy in the U.S. The company believes this reflects growing demand for advanced robotic solutions in peripheral endovascular procedures, a market estimated at 2.5 million procedures annually.
Key Highlights
- Microbot Medical secured its first Midwest-based account, a healthcare system in Michigan.
- This marks the first health network in Michigan and the greater Midwest U.S. to adopt the LIBERTY System.
- The adoption follows a recent announcement of a first healthcare system customer in North Carolina.
- The company's full market release strategy in the U.S. is showing continued execution and expansion.
- The U.S. market for peripheral endovascular procedures is approximately 2.5 million annually.
- LIBERTY is the only FDA-cleared, single-use, remotely operated robotic system for peripheral endovascular procedures.
- The LIBERTY System recently received regulatory approval from the Israeli Ministry of Health's AMAR Division.
Price Impact
More from MBOT